Stay updated on Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma
Sign up to get notified when there's something new on the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page.

Latest updates to the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe study record history now includes a new revision entry v3.6.6, updating the page to the latest release. The prior revision v3.6.5 is superseded in the history.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe study record history shows a new revision entry (v3.6.5) added and the previous revision (v3.6.4) removed, indicating a small platform update to the page.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision entry v3.6.4 was added to the study record history, replacing the prior v3.6.3; this reflects an updated release note for the page.SummaryDifference0.1%

- Check73 days agoChange DetectedThe study record history shows a new revision v3.6.3 replacing v3.6.2, indicating a small administrative update to the page's versioning.SummaryDifference0.1%

- Check80 days agoChange DetectedA new revision entry (v3.6.2) was added to the study record history, and the previous revision (v3.6.0) was removed from the visible history. This reflects an administrative update to the version history rather than changes to study content.SummaryDifference0.1%

- Check94 days agoChange DetectedA new site revision entry (v3.6.0) was added to the record history, replacing the previous revision (v3.5.5), indicating a software update to the history tracking.SummaryDifference0.6%

Stay in the know with updates to Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page.